![](/img/cover-not-exists.png)
The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments
Peter Connick, Madhan Kolappan, Rickie Patani, Michael A Scott, Charles Crawley, Xiao-Ling He, Karen Richardson, Kelly Barber, Daniel J Webber, Claudia AM Wheeler-Kingshott, Daniel J Tozer, Rebecca SVolume:
12
Language:
english
DOI:
10.1186/1745-6215-12-62
Date:
December, 2011
File:
PDF, 694 KB
english, 2011